Microbial production of triterpenoids including mogrosides
Inventors
PHILIPPE, Ryan • KUMARAN, Ajikumar Parayil • Santos, Christine Nicole S. • GOETTGE, MICHELLE N.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present invention provides host cells and methods for making mogrol glycosides, including Mogroside V (Mog. V), Mogroside VI (Mog. VI), Iso-Mogroside V (Isomog. V), and glycosylation products that are minor products in Siraitia grosvenorii. The invention provides engineered enzymes and engineered host cells for producing mogrol glycosylation products, such as Mog. V, Mog. VI, and Isomog. V, at high purity and/or yield. The present technology further provides methods of making products containing mogrol glycosides, such as Mog. V, Mog. VI, and Isomog. V, including food products, beverages, oral care products, sweeteners, and flavoring products.
Core Innovation
The invention provides a method for making a triterpenoid by providing a recombinant microbial host cell expressing a heterologous enzyme pathway that catalyzes conversion of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) to one or more triterpenoids. The pathway comprises a farnesyl diphosphate synthase (FPPS), a squalene synthase (SQS), and a squalene epoxidase (SQE), and the SQS comprises an amino acid sequence at least 85% identical to the amino acid sequence of SEQ ID NO: 11 while the SQE comprises an amino acid sequence at least 85% identical to the amino acid sequence of SEQ ID NO: 39.
The microbial host cell is a bacterium or yeast and is cultured at a temperature within 28° C. to 37° C. under conditions for producing the triterpenoid. Dependent claims broaden the pathway framework to include a triterpene cyclase and at least one oxidase, including cytochrome P450, and narrow the produced triterpenoid product class to mogrol and mogrol glycosides.
For generating mogrol glycosides, the pathway includes a triterpene cyclase, an epoxide hydrolase, oxidases including cytochrome P450 and reductase partner proteins and further electron-transfer proteins, and a uridine diphosphate glycosyltransferase (UGT). The glycosylation is described as sequential glycosylation at C3/C24 positions, including beta-1,2 and beta-1,6 branching, to generate specific mogrosides such as Mog. V, Mog. VI, and Isomog. V.
Claims Coverage
The claims cover a recombinant bacterium or yeast method for making one or more triterpenoids using a heterologous FPPS-SQS-SQE pathway, with SQS and SQE constrained by amino-acid identity thresholds to specified SEQ ID sequences, and culturing at 28° C. to 37° C. Dependent features add pathway enzymes and narrow the outputs to mogrol and mogrol glycosides.
Recombinant microbial host cell with a heterologous fpPS-sqs-sqe pathway for triterpenoid production
A method for making a triterpenoid by providing a recombinant microbial host cell expressing a heterologous enzyme pathway catalyzing conversion of IPP and DMAPP to one or more triterpenoids, comprising FPPS, SQS, and SQE.
SQS sequence identity constraint
SQS comprises an amino acid sequence that is at least 85% identical to the amino acid sequence of SEQ ID NO: 11.
SQE sequence identity constraint
SQE comprises an amino acid sequence that is at least 85% identical to the amino acid sequence of SEQ ID NO: 39.
Culturing at 28° C. to 37° C. in a bacterium or yeast
Culturing the host cell at a temperature within the range of 28° C. to 37° C. under conditions for producing the triterpenoid, wherein the microbial host cell is a bacterium or yeast.
Addition of a triterpene cyclase to the heterologous pathway
The heterologous enzyme pathway further includes a triterpene cyclase.
Oxidase activity defined to include cytochrome p450
At least one oxidase is a cytochrome P450 enzyme.
Pathway operation producing mogrol
The heterologous enzyme pathway produces mogrol.
Selection of mogrol glycosides from a specified set
The one or more mogrol glycosides are selected from a specified group of named mogrol glycosides.
The claims center on a recombinant bacterium or yeast expressing a heterologous IPP/DMAPP-to-triterpenoid pathway with SQS and SQE defined by minimum amino-acid identity thresholds to specified SEQ IDs, together with culturing at 28° C. to 37° C. Dependent features add a triterpene cyclase, oxidases such as cytochrome P450, and outputs limited to mogrol and named mogrol glycosides.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Foods and beverages are described in connection with product uses of the produced mogrol glycosides (mogrosides).
Sweetener and oral-care contexts are described in connection with product uses of the produced mogrol glycosides (mogrosides).
Interested in licensing this patent?